Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
AEterna Zentaris, Inc.
Commercial Physical And Biological Research Canada
Nasdaq: AEZS | Toronto Stock Exchange: AEZ
Company Description
AEterna Zentaris, Inc. is a late-stage drug development company, which specializes in oncology and endocrine therapy. The company investigates treatments for various cancers which includes colorectal, multiple myeloma, endometrial, ovarian, bladder cancer and prostate. Its pipeline encompasses compounds at all stages of development from drug discovery through marketed products. The company focuses on the development of perifosine, AEZS-108 and AEZS-130. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Quebec, Canada.
Similar to: Medivir AB, Advanced Cell Technology, Inc., Exelixis, Inc.
Featured Company
Zhaikmunai LP
Uralsk, KZ
Zhaikmunai LP is an independent oil and gas company. The company, through its wholly-owned subsidiary, Zhaikmunai LLP, is engaged… Learn more →
Social Monitor
You may also be interested in:
Exelixis, Inc.
South San Francisco, CA, US
Exelixis, Inc. develops human therapeutics by innovating therapies for cancer and other serious diseases to various pharmaceutical… Learn more →
Advanced Cell Technology,…
Marlborough, MA, US
Advanced Cell Technology, Inc. is a biotechnology company that develops cellular therapies for the treatment of rare and common diseases… Learn more →
Medivir AB
Stockholm, SE
Medivir is a research based pharmaceutical company focused on infectious diseases and Nordic market presences were we market 15 products… Learn more →